Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can One-Sided weakness predict muscle loss in seniors?

NCT ID NCT07414888

Knowledge-focused Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This observational study will compare muscle strength between the dominant and non-dominant sides of the body in 140 older adults aged 65 and older, both with and without sarcopenia (age-related muscle loss). Researchers will measure handgrip, biceps, and quadriceps strength to see if larger strength differences are linked to sarcopenia. The goal is to determine if simple strength tests could help identify those at risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help identify a simple way to screen for sarcopenia risk in older adults using strength measurements.
What could go wrong
This is an observational study, not a treatment trial. It may not find a clear link, and results may not apply to all older adults.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 140 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will include older adults aged 65 years and older who are evaluated in a hospital or outpatient clinic setting. Participants will be grouped as sarcopenic and non-sarcopenic according to established diagnostic criteria and will undergo standardized assessments of muscle strength, body composition, and physical performance.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 65 years or older * Ability to walk independently or with minimal assistance * Ability to understand and follow simple instructions * Willingness and ability to provide written informed consent * Availability of muscle strength measurements (handgrip, biceps, and quadriceps) Exclusion Criteria: * Lack of cooperation, moderate to severe dementia (e.g., MMSE \<24) or conditions impeding cooperation. * Those with severe cardiovascular disease * Those with pacemakers * Surgical/fracture/acute pain in the measured extremities within the last 6 months. * Neurological and muscular disease affecting the upper or lower extremity (acute stroke, severe peripheral neuropathy, etc.) * Active systemic disease attack significantly affecting the measurement.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sarcopenia in elderly are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sarcopenia in elderly Sarcopenia; muscle strength asymmetry; older adults

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul Physical Therapy and Rehabilitation Training and Research Hospital

    Istanbul, Bahçelievler, 34180, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.